{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T23:36:09Z","timestamp":1794008169190,"version":"4.8.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,8]],"date-time":"2021-06-08T00:00:00Z","timestamp":1623110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,8]],"date-time":"2021-06-08T00:00:00Z","timestamp":1623110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Progressive apraxia of speech is a neurodegenerative syndrome affecting spoken communication. Molecular pathology, biochemistry, genetics, and longitudinal imaging were investigated in 32 autopsy-confirmed patients with progressive apraxia of speech who were followed over 10 years. Corticobasal degeneration and progressive supranuclear palsy (4R-tauopathies) were the most common underlying pathologies. Perceptually distinct speech characteristics, combined with age-at-onset, predicted specific 4R-tauopathy; phonetic subtype and younger age predicted corticobasal degeneration, and prosodic subtype and older age predicted progressive supranuclear palsy. Phonetic and prosodic subtypes showed differing relationships within the cortico-striato-pallido-nigro-luysial network. Biochemical analysis revealed no distinct differences in aggregated 4R-tau while tau H1 haplotype frequency (69%) was lower compared to 1000+ autopsy-confirmed 4R-tauopathies. Corticobasal degeneration patients had faster rates of decline, greater cortical degeneration, and shorter illness duration than progressive supranuclear palsy. These findings help define the pathobiology of progressive apraxia of speech and may have consequences for development of 4R-tau targeting treatment.<\/jats:p>","DOI":"10.1038\/s41467-021-23687-8","type":"journal-article","created":{"date-parts":[[2021,6,8]],"date-time":"2021-06-08T10:07:47Z","timestamp":1623146867000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":66,"title":["A molecular pathology, neurobiology, biochemical, genetic and neuroimaging study of progressive apraxia of speech"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2930-8634","authenticated-orcid":false,"given":"Keith A.","family":"Josephs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph R.","family":"Duffy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather M.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rene L.","family":"Utianski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edythe A.","family":"Strand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary M.","family":"Machulda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4390-685X","authenticated-orcid":false,"given":"Hugo","family":"Botha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2244-6412","authenticated-orcid":false,"given":"Peter R.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nha Trang Thu","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Stierwalt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farwa","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Buciuc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristhoper H.","family":"Fernandez De Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Spychalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1466-8357","authenticated-orcid":false,"given":"Christopher G.","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2391-8650","authenticated-orcid":false,"given":"Robert I.","family":"Reid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew L.","family":"Senjem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7916-622X","authenticated-orcid":false,"suffix":"Jr","given":"Clifford R.","family":"Jack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val J.","family":"Lowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen H.","family":"Bigio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross R.","family":"Reichard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric. J.","family":"Polley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilufer","family":"Ertekin-Taner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Rademakers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"DeTure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4813-756X","authenticated-orcid":false,"given":"Owen A.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7189-7917","authenticated-orcid":false,"given":"Dennis W.","family":"Dickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Whitwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,8]]},"reference":[{"key":"23687_CR1","doi-asserted-by":"crossref","unstructured":"Darley, F.L. Lacunae and research approaches to them. in Brain Mechanisms Underlying Speech and Language (eds. Milliken, C. & Darley, F.L.) (Grune & Stratton, New York, 1967).","DOI":"10.1097\/00000441-196712000-00046"},{"key":"23687_CR2","unstructured":"Duffy, J.R. Motor Speech Disorders: Substrates, Differetial Diagnois, and Management (Mosby, St Louis, MI, 2005)."},{"key":"23687_CR3","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1093\/brain\/awh172","volume":"127","author":"AE Hillis","year":"2004","unstructured":"Hillis, A. E. et al. Re-examining the brain regions crucial for orchestrating speech articulation. Brain 127, 1479\u20131487 (2004).","journal-title":"Brain"},{"key":"23687_CR4","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1212\/WNL.0b013e3181c7198e","volume":"74","author":"V Deramecourt","year":"2010","unstructured":"Deramecourt, V. et al. Prediction of pathology in primary progressive language and speech disorders. Neurology 74, 42\u201349 (2010).","journal-title":"Neurology"},{"key":"23687_CR5","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1080\/02687030600597358","volume":"20","author":"J Duffy","year":"2006","unstructured":"Duffy, J. Apraxia of Speech in degenerative neurologic disease. Aphasiology 20, 511\u2013527 (2006).","journal-title":"Aphasiology"},{"key":"23687_CR6","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1080\/13554790590963004","volume":"11","author":"KA Josephs","year":"2005","unstructured":"Josephs, K. A. et al. Atypical progressive supranuclear palsy underlying progressive apraxia of speech and nonfluent aphasia. Neurocase 11, 283\u2013296 (2005).","journal-title":"Neurocase"},{"key":"23687_CR7","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1097\/WAD.0b013e31815d19fe","volume":"21","author":"JM Ogar","year":"2007","unstructured":"Ogar, J. M., Dronkers, N. F., Brambati, S. M., Miller, B. L. & Gorno-Tempini, M. L. Progressive nonfluent aphasia and its characteristic motor speech deficits. Alzheimer Dis. Assoc. Disord. 21, S23\u2013S30 (2007).","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"23687_CR8","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1044\/1058-0360(2007\/025)","volume":"16","author":"JR Duffy","year":"2007","unstructured":"Duffy, J. R., Peach, R. K. & Strand, E. A. Progressive apraxia of speech as a sign of motor neuron disease. Am. J. Speech Lang. Pathol. 16, 198\u2013208 (2007).","journal-title":"Am. J. Speech Lang. Pathol."},{"key":"23687_CR9","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1093\/brain\/aws032","volume":"135","author":"KA Josephs","year":"2012","unstructured":"Josephs, K. A. et al. Characterizing a neurodegenerative syndrome: primary progressive apraxia of speech. Brain 135, 1522\u20131536 (2012).","journal-title":"Brain"},{"key":"23687_CR10","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1007\/s00415-015-7821-5","volume":"262","author":"JL Whitwell","year":"2015","unstructured":"Whitwell, J. L. et al. Sample size calculations for clinical trials targeting tauopathies: a new potential disease target. J. Neurol. 262, 2064\u20132072 (2015).","journal-title":"J. Neurol."},{"key":"23687_CR11","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1212\/WNL.0b013e31829c5ed5","volume":"81","author":"KA Josephs","year":"2013","unstructured":"Josephs, K. A. et al. Syndromes dominated by apraxia of speech show distinct characteristics from agrammatic PPA. Neurology 81, 337\u2013345 (2013).","journal-title":"Neurology"},{"key":"23687_CR12","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.bandl.2018.06.004","volume":"184","author":"RL Utianski","year":"2018","unstructured":"Utianski, R. L. et al. Prosodic and phonetic subtypes of primary progressive apraxia of speech. Brain Lang. 184, 54\u201365 (2018).","journal-title":"Brain Lang."},{"key":"23687_CR13","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1093\/brain\/awu223","volume":"137","author":"KA Josephs","year":"2014","unstructured":"Josephs, K. A. et al. The evolution of primary progressive apraxia of speech. Brain 137, 2783\u20132795 (2014).","journal-title":"Brain"},{"key":"23687_CR14","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.parkreldis.2020.09.039","volume":"81","author":"ZI Seckin","year":"2020","unstructured":"Seckin, Z. I. et al. The evolution of parkinsonism in primary progressive apraxia of speech: A 6-year longitudinal study. Parkinsonism Relat. Disord. 81, 34\u201340 (2020).","journal-title":"Parkinsonism Relat. Disord."},{"key":"23687_CR15","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1080\/13554794.2018.1477963","volume":"24","author":"KA Tetzloff","year":"2018","unstructured":"Tetzloff, K. A. et al. Clinical and imaging progression over 10 years in a patient with primary progressive apraxia of speech and autopsy-confirmed corticobasal degeneration. Neurocase 24, 111\u2013120 (2018).","journal-title":"Neurocase"},{"key":"23687_CR16","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1002\/mdc3.12796","volume":"6","author":"JL Whitwell","year":"2019","unstructured":"Whitwell, J. L. et al. An evaluation of the progressive supranuclear palsy speech\/language variant. Mov. Disord. Clin. Pract. 6, 452\u2013461 (2019).","journal-title":"Mov. Disord. Clin. Pract."},{"key":"23687_CR17","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1212\/WNL.0000000000000412","volume":"82","author":"H Botha","year":"2014","unstructured":"Botha, H. et al. Nonverbal oral apraxia in primary progressive aphasia and apraxia of speech. Neurology 82, 1729\u20131735 (2014).","journal-title":"Neurology"},{"key":"23687_CR18","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.cortex.2016.09.017","volume":"90","author":"JL Whitwell","year":"2017","unstructured":"Whitwell, J. L. et al. Tracking the development of agrammatic aphasia: a tensor-based morphometry study. Cortex 90, 138\u2013148 (2017).","journal-title":"Cortex"},{"key":"23687_CR19","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1093\/brain\/awl078","volume":"129","author":"KA Josephs","year":"2006","unstructured":"Josephs, K. A. et al. Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech. Brain 129, 1385\u20131398 (2006).","journal-title":"Brain"},{"key":"23687_CR20","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1093\/hmg\/8.4.711","volume":"8","author":"M Baker","year":"1999","unstructured":"Baker, M. et al. Association of an extended haplotype in the tau gene with progressive supranuclear palsy. Hum. Mol. Genet. 8, 711\u2013715 (1999).","journal-title":"Hum. Mol. Genet."},{"key":"23687_CR21","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1002\/1531-8249(200003)47:3<374::AID-ANA15>3.0.CO;2-8","volume":"47","author":"E Di Maria","year":"2000","unstructured":"Di Maria, E. et al. Corticobasal degeneration shares a common genetic background with progressive supranuclear palsy. Ann. Neurol. 47, 374\u2013377 (2000).","journal-title":"Ann. Neurol."},{"key":"23687_CR22","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1002\/ana.10793","volume":"55","author":"T Arai","year":"2004","unstructured":"Arai, T. et al. Identification of amino-terminally cleaved tau fragments that distinguish progressive supranuclear palsy from corticobasal degeneration. Ann. Neurol. 55, 72\u201379 (2004).","journal-title":"Ann. Neurol."},{"key":"23687_CR23","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1093\/jnen\/61.11.935","volume":"61","author":"DW Dickson","year":"2002","unstructured":"Dickson, D. W. et al. Office of rare diseases neuropathologic criteria for corticobasal degeneration. J. Neuropathol. Exp. Neurol. 61, 935\u2013946 (2002).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"23687_CR24","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1212\/WNL.44.11.2015","volume":"44","author":"JJ Hauw","year":"1994","unstructured":"Hauw, J. J. et al. Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 44, 2015\u20132019 (1994).","journal-title":"Neurology"},{"key":"23687_CR25","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1097\/01.jnen.0000218446.38158.61","volume":"65","author":"KA Josephs","year":"2006","unstructured":"Josephs, K. A. et al. Atypical progressive supranuclear palsy with corticospinal tract degeneration. J. Neuropathol. Exp. Neurol. 65, 396\u2013405 (2006).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"23687_CR26","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s00401-013-1171-0","volume":"126","author":"Z Ahmed","year":"2013","unstructured":"Ahmed, Z. et al. Globular glial tauopathies (GGT): consensus recommendations. Acta Neuropathol.126, 537\u2013544 (2013).","journal-title":"Acta Neuropathol."},{"key":"23687_CR27","unstructured":"Love, S., Perry, A., Ironside, J.W. & Budka, H. Greenfield\u2019s Neuropathology (Taylor & Francis, Boca Raton, FL, 2015)."},{"key":"23687_CR28","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1093\/brain\/awm301","volume":"131","author":"Z Ahmed","year":"2008","unstructured":"Ahmed, Z., Josephs, K. A., Gonzalez, J., DelleDonne, A. & Dickson, D. W. Clinical and neuropathologic features of progressive supranuclear palsy with severe pallido-nigro-luysial degeneration and axonal dystrophy. Brain 131, 460\u2013472 (2008).","journal-title":"Brain"},{"key":"23687_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","volume":"123","author":"TJ Montine","year":"2012","unstructured":"Montine, T. J. et al. National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease: a practical approach. Acta Neuropathol. 123, 1\u201311 (2012).","journal-title":"Acta Neuropathol."},{"key":"23687_CR30","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1212\/WNL.0b013e31827f0fd1","volume":"80","author":"MJ Armstrong","year":"2013","unstructured":"Armstrong, M. J. et al. Criteria for the diagnosis of corticobasal degeneration. Neurology 80, 496\u2013503 (2013).","journal-title":"Neurology"},{"key":"23687_CR31","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1093\/brain\/awr179","volume":"134","author":"K Rascovsky","year":"2011","unstructured":"Rascovsky, K. et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 134, 2456\u20132477 (2011).","journal-title":"Brain"},{"key":"23687_CR32","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/mds.26987","volume":"32","author":"GU Hoglinger","year":"2017","unstructured":"Hoglinger, G. U. et al. Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria. Mov. Disord. 32, 853\u2013864 (2017).","journal-title":"Mov. Disord."},{"key":"23687_CR33","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1080\/13554794.2015.1041534","volume":"22","author":"EP Flanagan","year":"2016","unstructured":"Flanagan, E. P. et al. Mixed tau and TDP-43 pathology in a patient with unclassifiable primary progressive aphasia. Neurocase 22, 55\u201359 (2016).","journal-title":"Neurocase"},{"key":"23687_CR34","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1001\/jamaneurol.2016.0412","volume":"73","author":"MA Santos-Santos","year":"2016","unstructured":"Santos-Santos, M. A. et al. Features of patients with nonfluent\/agrammatic primary progressive aphasia with underlying progressive supranuclear palsy pathology or corticobasal degeneration. JAMA Neurol. 73, 733\u2013742 (2016).","journal-title":"JAMA Neurol."},{"key":"23687_CR35","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.1007\/s00415-020-09927-9","volume":"267","author":"P Choudhury","year":"2020","unstructured":"Choudhury, P. et al. Pick\u2019s disease: clinicopathologic characterization of 21 cases. J. Neurol. 267, 2697\u20132704 (2020).","journal-title":"J. Neurol."},{"key":"23687_CR36","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/nature05016","volume":"442","author":"M Baker","year":"2006","unstructured":"Baker, M. et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 442, 916\u2013919 (2006).","journal-title":"Nature"},{"key":"23687_CR37","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1212\/WNL.0000000000000031","volume":"82","author":"F Caso","year":"2014","unstructured":"Caso, F. et al. In vivo signatures of nonfluent\/agrammatic primary progressive aphasia caused by FTLD pathology. Neurology 82, 239\u2013247 (2014).","journal-title":"Neurology"},{"key":"23687_CR38","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1080\/02687038.2020.1836319","volume":"35","author":"M Mailend","year":"2020","unstructured":"Mailend, M. & Mass, E. To lump or to split? Possible subtypes of apraxia of speech. Aphasiology 35, 592\u2013613 (2020).","journal-title":"Aphasiology"},{"key":"23687_CR39","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1161\/STROKEAHA.115.009211","volume":"46","author":"A Basilakos","year":"2015","unstructured":"Basilakos, A., Rorden, C., Bonilha, L., Moser, D. & Fridriksson, J. Patterns of poststroke brain damage that predict speech production errors in apraxia of speech and aphasia dissociate. Stroke 46, 1561\u20131566 (2015).","journal-title":"Stroke"},{"key":"23687_CR40","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.bandl.2014.01.004","volume":"129","author":"J Graff-Radford","year":"2014","unstructured":"Graff-Radford, J. et al. The neuroanatomy of pure apraxia of speech in stroke. Brain Lang. 129, 43\u201346 (2014).","journal-title":"Brain Lang."},{"key":"23687_CR41","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.nicl.2015.03.013","volume":"8","author":"AB New","year":"2015","unstructured":"New, A. B. et al. Altered resting-state network connectivity in stroke patients with and without apraxia of speech. Neuroimage Clin. 8, 429\u2013439 (2015).","journal-title":"Neuroimage Clin."},{"key":"23687_CR42","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1212\/01.wnl.0000196469.52995.ab","volume":"66","author":"SA Factor","year":"2006","unstructured":"Factor, S. A., Higgins, D. S. & Qian, J. Primary progressive freezing gait: a syndrome with many causes. Neurology 66, 411\u2013414 (2006).","journal-title":"Neurology"},{"key":"23687_CR43","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1136\/jnnp.55.7.577","volume":"55","author":"E Broussolle","year":"1992","unstructured":"Broussolle, E., Tommasi, M., Mauguiere, F. & Chazot, G. Progressive anarthria with secondary parkinsonism: a clinico-pathological case report. J. Neurol. Neurosurg. Psychiatry 55, 577\u2013580 (1992).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"23687_CR44","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1111\/ene.12212","volume":"20","author":"JL Whitwell","year":"2013","unstructured":"Whitwell, J. L. et al. Midbrain atrophy is not a biomarker of progressive supranuclear palsy pathology. Eur. J. Neurol. 20, 1417\u20131422 (2013).","journal-title":"Eur. J. Neurol."},{"key":"23687_CR45","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1212\/WNL.0b013e318292a2d2","volume":"80","author":"LA Massey","year":"2013","unstructured":"Massey, L. A. et al. The midbrain to pons ratio: a simple and specific MRI sign of progressive supranuclear palsy. Neurology 80, 1856\u20131861 (2013).","journal-title":"Neurology"},{"key":"23687_CR46","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.neurobiolaging.2006.09.019","volume":"29","author":"KA Josephs","year":"2008","unstructured":"Josephs, K. A. et al. Voxel-based morphometry in autopsy proven PSP and CBD. Neurobiol. Aging 29, 280\u2013289 (2008).","journal-title":"Neurobiol. Aging"},{"key":"23687_CR47","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1093\/brain\/awz157","volume":"142","author":"KA Tetzloff","year":"2019","unstructured":"Tetzloff, K. A. et al. Progressive agrammatic aphasia without apraxia of speech as a distinct syndrome. Brain 142, 2466\u20132482 (2019).","journal-title":"Brain"},{"key":"23687_CR48","doi-asserted-by":"publisher","first-page":"e102656","DOI":"10.1371\/journal.pone.0102656","volume":"9","author":"F Tovar-Moll","year":"2014","unstructured":"Tovar-Moll, F. et al. White matter tract damage in the behavioral variant of frontotemporal and corticobasal dementia syndromes. PLoS ONE 9, e102656 (2014).","journal-title":"PLoS ONE"},{"key":"23687_CR49","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1136\/jmg.2005.031377","volume":"42","author":"AM Pittman","year":"2005","unstructured":"Pittman, A. M. et al. Linkage disequilibrium fine mapping and haplotype association analysis of the tau gene in progressive supranuclear palsy and corticobasal degeneration. J. Med. Genet. 42, 837\u2013846 (2005).","journal-title":"J. Med. Genet."},{"key":"23687_CR50","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/bpa.12924","volume":"31","author":"JJ Llibre-Guerra","year":"2021","unstructured":"Llibre-Guerra, J. J. et al. A novel temporal-predominant neuro-astroglial tauopathy associated with TMEM106B gene polymorphism in FTLD\/ALS-TDP. Brain Pathol. 31, 267\u2013282 (2021).","journal-title":"Brain Pathol."},{"key":"23687_CR51","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s00401-013-1240-4","volume":"127","author":"M van Blitterswijk","year":"2014","unstructured":"van Blitterswijk, M. et al. TMEM106B protects C9ORF72 expansion carriers against frontotemporal dementia. Acta Neuropathol. 127, 397\u2013406 (2014).","journal-title":"Acta Neuropathol."},{"key":"23687_CR52","doi-asserted-by":"crossref","unstructured":"Kertesz, A. Western aphasia battery (Revised), (PsychCorp, San Antonio, Tx, 2007).","DOI":"10.1037\/t15168-000"},{"key":"23687_CR53","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1093\/brain\/85.4.665","volume":"85","author":"E De Renzi","year":"1962","unstructured":"De Renzi, E. & Vignolo, L. A. The token test: a sensitive test to detect receptive disturbances in aphasics. Brain 85, 665\u2013678 (1962).","journal-title":"Brain"},{"key":"23687_CR54","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1177\/1533317509343104","volume":"24","author":"S Weintraub","year":"2009","unstructured":"Weintraub, S. et al. The northwestern anagram test: measuring sentence production in primary progressive aphasia. Am. J. Alzheimers Dis. Other Demen 24, 408\u2013416 (2009).","journal-title":"Am. J. Alzheimers Dis. Other Demen"},{"key":"23687_CR55","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1093\/arclin\/14.6.481","volume":"14","author":"AE Lansing","year":"1999","unstructured":"Lansing, A. E., Ivnik, R. J., Cullum, C. M. & Randolph, C. An empirically derived short form of the Boston naming test. Arch. Clin. Neuropsychol. 14, 481\u2013487 (1999).","journal-title":"Arch. Clin. Neuropsychol."},{"key":"23687_CR56","doi-asserted-by":"crossref","unstructured":"Dunn, L.A. & Dunn, L.M. Peabody Picture Vocabulary Test-4 (Pearson Canada Assessment, Ontario, 2006).","DOI":"10.1037\/t15144-000"},{"key":"23687_CR57","first-page":"35","volume":"1","author":"K Yorkson","year":"1993","unstructured":"Yorkson, K., Strand, E. A., Miller, R., Hillel, A. & Smith, K. Speech deterioration in amyotrophic lateral sclerosis: Implications for the timing of intervention. J. Med. Speech Lang. Pathol. 1, 35\u201346 (1993).","journal-title":"J. Med. Speech Lang. Pathol."},{"key":"23687_CR58","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1207\/S15324826AN0803_5","volume":"8","author":"AS Loonstra","year":"2001","unstructured":"Loonstra, A. S., Tarlow, A. R. & Sellers, A. H. COWAT metanorms across age, education, and gender. Appl Neuropsychol. 8, 161\u2013166 (2001).","journal-title":"Appl Neuropsychol."},{"key":"23687_CR59","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jcomdis.2014.06.008","volume":"51","author":"EA Strand","year":"2014","unstructured":"Strand, E. A., Duffy, J. R., Clark, H. M. & Josephs, K. The apraxia of speech rating scale: a tool for diagnosis and description of apraxia of speech. J. Commun. Disord. 51, 43\u201350 (2014).","journal-title":"J. Commun. Disord."},{"key":"23687_CR60","unstructured":"Lezak, M.D., Howieson, D.B., Bigler, E.D. & Tranel, D. Neuropsychological Assessment (Oxford University Press, New York, 2012)."},{"key":"23687_CR61","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1016\/j.neuroimage.2009.09.062","volume":"49","author":"BB Avants","year":"2010","unstructured":"Avants, B. B. et al. The optimal template effect in hippocampus studies of diseased populations. NeuroImage 49, 2457\u20132466 (2010).","journal-title":"NeuroImage"},{"key":"23687_CR62","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1212\/WNL.41.4.479","volume":"41","author":"SS Mirra","year":"1991","unstructured":"Mirra, S. S. et al. The Consortium to Establish a Registry for Alzheimer\u2019s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer\u2019s disease. Neurology 41, 479\u2013486 (1991).","journal-title":"Neurology"},{"key":"23687_CR63","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1212\/WNL.56.suppl_4.S16","volume":"56","author":"DW Dickson","year":"2001","unstructured":"Dickson, D. W. Neuropathology of Pick\u2019s disease. Neurology 56, S16\u2013S20 (2001).","journal-title":"Neurology"},{"key":"23687_CR64","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1007\/s12031-011-9589-0","volume":"45","author":"DW Dickson","year":"2011","unstructured":"Dickson, D. W., Kouri, N., Murray, M. E. & Josephs, K. A. Neuropathology of frontotemporal lobar degeneration-tau (FTLD-tau). J. Mol. Neurosci. 45, 384\u2013389 (2011).","journal-title":"J. Mol. Neurosci."},{"key":"23687_CR65","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00401-011-0845-8","volume":"122","author":"IR Mackenzie","year":"2011","unstructured":"Mackenzie, I. R. et al. A harmonized classification system for FTLD-TDP pathology. Acta Neuropathol. 122, 111\u2013113 (2011).","journal-title":"Acta Neuropathol."},{"key":"23687_CR66","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak, H. & Braak, E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol.82, 239\u2013259 (1991).","journal-title":"Acta Neuropathol."},{"key":"23687_CR67","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/0165-0270(94)90168-6","volume":"53","author":"R Crook","year":"1994","unstructured":"Crook, R., Hardy, J. & Duff, K. Single-day apolipoprotein E genotyping. J. Neurosci. Methods 53, 125\u2013127 (1994).","journal-title":"J. Neurosci. Methods"},{"key":"23687_CR68","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/31508","volume":"393","author":"M Hutton","year":"1998","unstructured":"Hutton, M. et al. Association of missense and 5\u2019-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393, 702\u2013705 (1998).","journal-title":"Nature"},{"key":"23687_CR69","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.neuron.2011.09.011","volume":"72","author":"M DeJesus-Hernandez","year":"2011","unstructured":"DeJesus-Hernandez, M. et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72, 245\u2013256 (2011).","journal-title":"Neuron"},{"key":"23687_CR70","doi-asserted-by":"crossref","unstructured":"Gelman, A. & Hill, J. Data Analysis Using Regression and Multilevel\/Hierarchical Models (Cambridge University Press, New York, NY, 2006).","DOI":"10.1017\/CBO9780511790942"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-23687-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-23687-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-23687-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T12:37:09Z","timestamp":1669984629000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-23687-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,8]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["23687"],"URL":"https:\/\/doi.org\/10.1038\/s41467-021-23687-8","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,8]]},"assertion":[{"value":"28 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"C.R.J. serves on an independent data monitoring board for Roche, has consulted for and served as a speaker for Eisai, and consulted for Biogen, but he receives no personal compensation from any commercial entity. V.J.L. is a consultant for AVID Radiopharmaceuticals, Eisai Co. Inc., Bayer Schering Pharma, GE Healthcare, and Merck Research, and receives research support from GE Healthcare, Siemens Molecular Imaging, and AVID Radiopharmaceuticals. M.L.S. owns stocks in Align Technology, Inc., Inovio Pharmaceuticals Inc., LHC Group, Inc., Mesa Laboratories, Inc., Natus Medical Inc., and Varex Imaging Corporation. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3452"}}